1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • December 2016
  • -
  • Mordor Intelligence LLP
  • -
  • 90 pages

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application in diagnosis and treatment of diseases. The drugs containing radionuclides are called radiopharmaceuticals. The uses in radiological imaging include Magnetic Resonance Imaging (MRI), Computerized tomography (CT), Positron Emission Tomography (PET) and Single Proton Emission Tomography (SPECT).

The use of nuclear medicines for diagnostic purposes has gained huge popularity all around the world. There has been increased use of SPECT, PET, CT, and MRI for diagnosis of cardiac diseases, brain diseases, cancer and many others. Nuclear medicine is being used for therapeutic purposes for treatment of Alzheimer’s disease, coronary heart diseases, bone metastasis, cancers and different medical conditions affecting the thyroid gland, and scar tissue removal. Advancement in diagnostic imaging is bringing in more use of nuclear medicine. Nuclear cardiology has gained great popularity in North America.

Global Nuclear Medicines Market- Market Dynamics

The report lists several driving and restraining factors for the global nuclear medicines market. In addition, it sheds light on several opportunities that exist for the market players. Some of these are listed below.

Drivers

Increasing incidence and prevalence of cancer and cardiac ailments
Increasing application of SPECT and PET with advancement of technology
Growing awareness amongst physicians
Public awareness for better healthcare
Restraints

Short half-life of radiopharmaceuticals
High capital investment required for development
Stringent regulatory guidelines
Opportunities

Increasing imaging technologies
Potential radioisotopes in pipeline
Increasing neurological applications and cyclotron based production
The global nuclear medicine market has been segmented based on type, application, and geography.

Based on the type of product, the market has been segmented into the diagnostic market and therapeutic market, wherein the diagnostics market has been further subdivided into SPECT radioisotopes that include Technetium-993, Thallium-201, Iodine-123, Gallium and PET radioisotopes (subdivided intoRubidium-82, Flourine-18). The therapeutics category has been segmented into Alpha emitters (Radium-223), Beta Emitters (includes Iodine-131, Samarium-153, Lutetium-177, Yttrium-90) and Brachytherapy (includes iodine-125, Cesium-131, Palladium-103, & Iridium-192).

The segmentation based on the application has been similarly subdivided based on diagnostic and therapeutic application. The diagnostic application includes the application of SPECT and PET in cardiology, neurology, oncology and others. The therapeutic applications include application in oncology, thyroid, endocrinology and various other therapeutic areas.

The global nuclear medicine market has been geographically segmented into North America (includes United States, Canada, and Mexico), Europe (includes Germany, UK, France, Italy Spain, Russia and Others), Asia-Pacific (includes China, Japan, India, Australia South Korea and Others), Middle East and Africa (includes UAE, Saudi Arabia, Israel, and others), and Latin America (includes Brazil, Argentina, Mexico, and others). Due to high technological advancement coupled with a developed economy, North America has the largest market share, followed by Europe and Asia-Pacific.

Currently, the segment of diagnostics holds the largest share in nuclear medicines market, where SPECT has the largest share. In the segmentation based on type, the Beta Emitters hold the largest share.

Some of the key players in the market are:

Bracco Imaging S.P.A.
BRACCO PHARMA
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary of General Electric Company)
Nordion, Inc.
Taiyo Nippon Sanso Corporation
What the report offers

Market definition for the nuclear medicines market along with identification of key drivers and restraints for the market.
Market analysis for the nuclear medicines market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the nuclear medicines market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table Of Contents

Global Nuclear Medicine Market
1. INTRODUCTION

1.1 REPORT DESCRIPTION

1.2 MARKETS COVERED

1.3 MAJOR STAKEHOLDERS

1.4 RESEARCH METHODOLOGY

2 EXECUTIVE SUMMARY

3. MARKET OVERVIEW

3.1 Market Drivers

3.1.1 Increasing Incidents of Cancer and Cardiac Ailments

3.1.2 Increasing SPECT AND PET applications

3.1.3 Growing Public Awareness for healthcare

3.2 MARKET CONSTRAINTS

3.2.1 Short Half-life of Radiopharmaceuticals

3.2.2 High Capital Investment

3.2.3 Regulatory Guidelines

3.2.4 Reimbursement

3.3 OPPORTUNITIES

3.3.1 Increasing Imaging Technologies

3.3.2 Potential Radioisotopes in Pipeline

3.3.3 Increasing Neurological Applications

3.3.4 Cyclotron based production

3.4 THREATS

3.4.1 Shutdown of Nuclear Reactors

4. GLOBAL NUCLEAR MEDICINE MARKET SEGMENTATION

4.1 Introduction

4.2 Global Market: Segmentation by Diagnostics

4.2.1 Introduction

4.2.2 SPECT Market

4.2.3 PET Market

4.3 Global Market: Segmentation by Therapeutics

4.3.1 Introduction

4.3.2 Alpha Emitters

4.3.3 Beta Emitters

4.3.4 Brachytherapy

4.4 GLOBAL MARKET SEGMENTATION BY APPLICATION

4.4.1 SPECT Market

4.4.2 PET Market

4.5 MARKET SEGMENTATION BY GEOGRAPHY

4.5.1 North America Nuclear Medicine Market

4.5.1.1 UNITED STATES

4.5.1.2 CANADA

4.5.1.3 MEXICO

4.5.2 EUROPE

4.5.2.1 GERMANY

4.5.2.2 UNITED KINGDOM

4.5.2.3 FRANCE

4.5.2.4 SPAIN

4.5.2.5 ITALY

4.5.3 ASIA - PACIFIC

4.5.3.1 India

4.5.3.2 China

4.5.3.3 South Korea

4.5.3.4 Japan

5. COMPETITIVE LANDSCAPE

5.1 MERGERS, ACQUISITIONS and SPIN OFFS

5.2 COLLABORATIONS

5.3 PRODUCT LAUNCHES

6. PROFILES OF KEY COMPANIES

6.1 MALLINCKRODT

6.2 LANTHEUS MEDICAL IMGAGING

6.3 IBA GROUP

6.4 TRIAD ISOTOPE

6.5 SIEMENS HEALTHCARE

6.6 NTP RADIOISOTOPES

6.7 Bracco Imaging S.P.A.

6.8 BRACCO PHARMA

6.9 Cambridge Isotope Laboratories, Inc.

6.10 Cardinal Health, Inc.

6.11 GE Healthcare (Subsidiary of General Electric Company)

6.12 Nordion, Inc.

6.13 Taiyo Nippon Sanso Corporation

6.14 Fujifilm Holdings Corporation

6.15 Eczacibasi-Monrol

6.16 Isotec, Inc. (Sigma-Aldrich)

6.17 Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.)

7. Appendix

7.1 Abbreviations

7.2 Sources

7.3 Bibliography

7.4 Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2025

Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Nuclear Medicine is poised to grow at a CAGR of around 10.2% over the next decade to reach approximately $11.3 billion by 2025. Some of the prominent trends that the market is witnessing include ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.